Showing results (801-810 of 854) with videos related to
Sort By:
Pageof 86
British Journal of Cancer|October 31, 2014
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplificationR Defferrari, K Mazzocco, I M Ambros, et al.Circulation|November 8, 2014
Endovascular treatment of mycotic aortic aneurysms: a European multicenter studyKarl Sörelius, Kevin Mani, Martin Björck, et al.Frontiers in Cardiovascular Medicine|April 16, 2026
Co-produced evidence-based recommendations for cascade screening and secondary prevention in the relatives of people diagnosed with non-syndromic thoracic aortic diseaseR G Abbasciano, J C Dionne, J Miksza, et al.BMJ Open|May 18, 2026
Comparison of iloprost therapy versus non-iloprost therapy for severe frostbite: a retrospective cohort study of two Canadian citiesDomhnall O'Dochartaigh, Matthew J Douma, Christopher Picard, et al.Journal of Clinical Pathology|August 30, 2022
Increasing test specificity without impairing sensitivity: lessons learned from SARS-CoV-2 serologyThomas Perkmann, Thomas Koller, Nicole Perkmann-Nagele, et al.Blood Advances|July 3, 2023
Polygenic risk of major depressive disorder as a risk factor for venous thromboembolismJoey Ward, Ngoc-Quynh Le, Suryakant Suryakant, et al.JAMA Cardiology|December 1, 2017
Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysisSeamus C Harrison, Michael V Holmes, Stephen Burgess, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Quality assessment of genetic markers used for therapy stratificationI M Ambros, J Benard, M Boavida, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
A multilocus technique for risk evaluation of patients with neuroblastomaInge M Ambros, Bettina Brunner, Gerhard Aigner, et al.British Journal of Cancer|December 8, 2011
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)G Schleiermacher, J Michon, A Ribeiro, et al.Pageof 86